Polymers and Scaffolds with Improved Blood Compatibility and Enhanced Cellular Response with Focus on Polyurethane Foams Functionalized with Amino-Amide Groups
DOI:
https://doi.org/10.12970/2311-1755.2019.07.03Keywords:
Polyurethane foams, scaffold, functionalization, bioactive molecule, PIME, open porosity, compressive properties, cell interactions, L929, fibroblasts.Abstract
Biofunctionalization of biomaterial substrates has gained increasing interest in Tissue Engineering (TE) to create functional scaffolds with improved performances and capable of directing cellular behaviour. This work takes into account the functionalization of polyurethane (PU) foams with an active molecule, the diamino-diamide diol PIME, purposely designed to be inserted in the structure of linear PUs and previously found to be able to improve hemo-, cytocompatibility and bacterial resistance of these biomaterials. Here, for the first time, the gas foaming process previously set up for biocompatible PU foams was modified, and different methods were tested to obtain structurally stable foams containing PIME. The obtained foams and respective controls showed appropriate porosity (Ø = 407 ÷ 589 ± 30 mm; > 90% open porosity), similar density (» 0.14 g/cm3) and hydrophilicity (water uptake » 300%) and adequate compressive properties (E = 0.058 ÷ 0.170 Mpa; Hysteresis Area = 2.07 ÷ 5.59 x 10-3 J/cm3, < 5% residual deformation). PU foams containing PIME exhibited a more spherical pore geometry; the foam obtained by applying a higher stirring speed during synthesis (PU-3kP) exhibited a lower mean pore size and an elastic modulus higher than that of the other foams. FT-IR spectroscopy indicated the presence of new absorption bands and structural changes attributable to the presence of PIME. Cytotoxicity tests performed with the cell line L929 verified the absence of cytotoxic effects. All foams were able to support L929 fibroblasts proliferation and vitality for seven days; PIME-containing foams showed higher values of cell proliferation (p<0.05) that the respective controls.
References
Tanzi MC, Farè S, Candiani G. Tissue Engineering. In: Foundations of Biomaterials Engineering, Chapter 8.1. London: Academic Press 2019; pp. 471-512. https://doi.org/10.1016/B978-0-08-101034-1.00008-6
Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009; 8: 457-470. https://doi.org/10.1038/nmat2441
Bramfeldt H, Sabra G, Centis V, Vermette P. Scaffold Vascularization: A Challenge for Three-Dimensional Tissue Engineering. Current Medicinal Chemistry 2010; 17(33): 3944-67. https://doi.org/10.2174/092986710793205327
Tanzi MC. Bioactive technologies for hemocompatibility. Expert Rev. Med. Devices 2005; 2(4): 473-492. https://doi.org/10.1586/17434440.2.4.473
Stevens MM, George JH. Exploring and engineering the cell surface interface. Science 2005; 310: 1135-8. https://doi.org/10.1126/science.1106587
Byun Y, Jacobs HA, Kim SW. Mechanism of thrombin inactivation by immobilized heparin. J Biomed Mater Res 1996; 30: 423-427. https://doi.org/10.1002/jbm.820300403
Oduah EI, Linhardt RJ, Sharfstein ST. Heparin: Past, Present, and Future. Pharmaceuticals 2016; 9(38): 12. https://doi.org/10.3390/ph9030038
Ferruti P, Marchisio MA, Duncan R. Poly(amido‐amine)s: Biomedical Applications. Macromolecular Rapid Communications 2002; 23(5-6): 332-355. https://doi.org/10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
Tanzi MC, Barzaghi B, Anouchinsky R, Bilenkis S, Penhasi A, Cohn D. Grafting reactions and heparin adsorption of poly (amidoamine)-grafted poly (urethane amide)s. Biomaterials 1992; 13(7): 425-31. https://doi.org/10.1016/0142-9612(92)90162-H
Albanese A, Barbucci R, Belleville J, Bowry S, Eloy R, Lemke HD, Sabatini L. In vitro biocompatibility evaluation of a heparinizable material (PUPA) based on polyurethane and poly (amido-amine) components. Biomaterials 1994; 15: 129-136. https://doi.org/10.1016/0142-9612(94)90262-3
Tanzi MC. US5,955,560 Patent 1999. https://doi.org/10.1001/archopht.117.7.955
Tanzi MC. US6,143,893 Patent 2000. https://doi.org/10.1046/j.1365-2133.2000.03855.x
Tanzi MC, Perini P, Farè S. Advanced polyurethanes for blood-contacting applications containing PIME as “smart” heparin-adsorbing moieties. In: Thomas DW, Ed.Advanced Biomaterials for Medical Applications. Dordrecht: Kluwer Academic Publ 2004; pp. 51-66. https://doi.org/10.1007/978-1-4020-2908-0_5
Petrini P, Tanzi MC, Visai L, Casolini F, Speziale P. Novel Polyurethane-aminoamides: an in vitro study of the interaction with heparin. J Biomaterial Science Polymer Edition 2000; 11: 353-365. https://doi.org/10.1163/156856200743751
Petrini P, Farè S, Bozzini S, Tanzi MC. Innovative Heparin-Binding Polyurethane Hydrogel: Synthesis and Properties. In: Proc. of the VII World Biomaterials Congress 2004; p. 619.
Petrini P, Visai L, Speziale P, Tanzi MC. HEPITAN: Heparin-Adsorbing Properties. In: Transaction 6th World Biomaterials Congress 2000; p. 433.
Ward RS, McCrea KR, Tian Y, Tanzi MC. Use of SFG to Optimize a Polyurethane with Heparin Binding Sites Incorporated During Synthesis. In: Proceedings of the 7th World Biomaterials Congress 2004; p. 433.
De Nardo L, Farè S, Di Matteo V, Cipolla E, Saino E, Visai L, Speziale P, Tanzi MC. New heparinizable modified poly(carbonate urethane) surfaces diminishing bacterial colonization. J Mater Sci: Mater Med 2007; 18: 2109-2115. https://doi.org/10.1007/s10856-007-3083-9
Szycher M, Szycher’s Handbook of polyurethanes, 2nd Edition, Boca Raton: CRC 2013. https://doi.org/10.1201/b12343
Janik H, Marzec M. A review: Fabrication of porous polyurethane scaffolds. Materials Science and Engineering: C 2015; 48: 586-591. https://doi.org/10.1016/j.msec.2014.12.037
Gama NV, Ferreira A, Barros-Timmons A. Polyurethane Foams: Past, Present, and Future. Materials 2018; 11(10): 1841. https://doi.org/10.3390/ma11101841
Tanzi MC, Farè S, Petrini P, Tanini A, Piscitelli E, Zecchi Orlandini S, Brandi ML. Cytocompatibility of polyurethane foams as biointegrable matrices for the preparation of scaffolds for bone reconstruction. J Appl Biomater Biomech 2003; 1(1): 58-66. https://doi.org/10.1177/228080000300100107
Zanetta M, Quirici N, Demarosi F, Tanzi MC, Rimondini L, Farè S. Ability of polyurethane foams to support cell proliferation and the differentiation of MSCs into osteoblasts. Acta Biomater 2009; 5: 1126-1136. https://doi.org/10.1016/j.actbio.2008.12.003
Bertoldi S, Farè S, Denegri M, Rossi D, Haugen HJ, Parolini O, Tanzi MC. Ability of polyurethane foams to support placenta-derived cell adhesion and osteogenic differentiation: Preliminary results. J Mater Sci Mater Med 2010; 21: 1005-1011. https://doi.org/10.1007/s10856-009-3953-4
Meskinfam M, Bertoldi S, Albanese N, Cerri A, Tanzi MC, Imani R, Baheiraei N, Farokhi M, Farè S. Polyurethane foam/nano hydroxyapatite composite as a suitable scaffold for bone tissue regeneration. Materials Science and Engineering C 2018; 82: 130-140. https://doi.org/10.1016/j.msec.2017.08.064
Angeloni V, Contessi N, De Marco C, Bertoldi S, Tanzi MC, Daidone MG, Farè S. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis. Acta Biomaterialia 2017; 63: 306-316. https://doi.org/10.1016/j.actbio.2017.09.017
UNI EN ISO 845: 2006, “Cellular plastics and rubbers - Determination of apparent density.
Nakayama GR, Caton MC, Nova MP, Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997; 204: 205-8. https://doi.org/10.1016/S0022-1759(97)00043-4
Tanzi MC, Gantz D, Bertoldi S, Negrini NC, Haugen HJ. Functionalized polyurethane foams as tissue scaffolds with enhanced cellular response. In: Transactions of the Annual Meeting of the Society for Biomaterials 2009; p. 691.
